ATMI INC
10-Q, 1998-05-14
GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC
Previous: FRANKLIN FLOATING RATE TRUST, 486BPOS, 1998-05-14
Next: TUNLAW CAPITAL CORP, 10QSB, 1998-05-14



                      SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 10-Q


[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934


For the quarterly period ended March 31, 1998


[ ]  TRANSITION  REPORT  PURSUANT  TO SECTION  13 OR 15(d) OF THE  SECURITIES
     EXCHANGE ACT OF 1934


For the transition period from __________ to __________


Commission file Number: 0-22756


                                   ATMI, Inc.
             (Exact name of registrant as specified in its charter)


        Delaware                                        06-1481060
(State or other jurisdiction of             (I.R.S. Employer Identification No.)
 incorporation or organization)


 7 Commerce Drive, Danbury, CT                             06810
 (Address of principal executive offices)               (Zip Code)



                                  203-794-1100
              (Registrant's telephone number, including area code)







- - --------------------------------------------------------------------------------
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes x No __


The number of shares  outstanding of the  registrant's  common stock as of April
30, 1998 was 20,441,942.



<PAGE>
                                   ATMI, INC.
                          Quarterly Report on Form 10-Q
                      For the Quarter Ended March 31, 1998

                                TABLE OF CONTENTS
                                                                            Page
Part I - Financial Information

Item 1. Financial Statements

     Consolidated Balance Sheet.............................................. 3

     Consolidated Statement of Income........................................ 4

     Consolidated Statement of Cash Flows.................................... 5

     Notes to Consolidated Interim Financial Statements...................... 6


Item 2.  Management's  Discussion  and Analysis of Financial
               Condition  and Results of Operations.......................... 9


Item 3. Quantitative and Qualitative Disclosures about Market Risk.......... 12


Part II - Other Information

Item 6. Exhibits and Reports on Form 8-K.................................... 12



Signatures.................................................................. 14



<PAGE>

PART I - FINANCIAL INFORMATION
Item 1. Financial Statements

<TABLE>
                                   ATMI, Inc.
                           Consolidated Balance Sheet

<CAPTION>
                                                     March 31,      December 31,
                                                       1998             1997
                                                   (unaudited)
<S>                                               <C>            <C>
Assets
Current assets:
   Cash and cash equivalents                      $ 12,628,000   $   11,550,000
   Marketable securities                            71,449,000       17,461,000
   Accounts receivable, net of allowance for
      doubtful accounts of $448,000 in 1998
      and $405,000 in 1997                          20,164,000       19,784,000
   Notes and other receivables                       1,212,000        1,197,000
   Inventories                                       9,291,000        7,717,000
   Other                                             2,700,000        2,873,000
                                                     ---------        ---------

Total current assets                               117,444,000       60,582,000

Property and equipment, net                         36,810,000       36,032,000

Goodwill and other long-term assets, net             6,493,000        6,532,000
                                                  ------------     ------------

                                                  $160,747,000     $103,146,000
                                                  ============     ============

Liabilities and stockholders' equity
  Current liabilities:
   Accounts payable                               $   5,286,000   $   4,977,000
   Accrued expenses                                   6,260,000       6,436,000
   Accrued commissions                                2,464,000       2,113,000
   Notes payable, current portion                     2,163,000       2,655,000
   Capital lease obligations, current portion         2,395,000       2,671,000
   Income taxes and other current payables              722,000       1,797,000
                                                  -------------   -------------

Total current liabilities                            19,290,000      20,649,000

Notes payable, less current portion                   8,414,000       8,288,000
Capital lease obligations                             5,621,000       6,238,000
Deferred income taxes and other long-term
    liability                                         4,439,000       5,504,000

Minority interest                                       650,000         595,000


Stockholders' equity:
    Preferred stock, par value $.01: 2,000,000
      shares authorized; none issued and outstanding       -               -
    Common stock, par value $.01: 30,000,000 shares
      authorized; issued and outstanding 20,181,701
      in 1998 and 18,149,676 in 1997                    202,000         181,000
    Additional paid-in capital                       96,253,000      40,451,000
    Cumulative translation adjustment                  (926,000)     (1,099,000)
    Retained earnings                                26,804,000      22,339,000
                                                  --------------   -------------
Total stockholders' equity                          122,333,000      61,872,000
                                                  -------------    -------------

                                                  $ 160,747,000   $ 103,146,000
                                                  =============   =============
</TABLE>
See accompanying notes.

<PAGE>

<TABLE>
                                   ATMI, Inc.
                        Consolidated Statement of Income
                                   (unaudited)
<CAPTION>
                                                   Three months ended March 31,
                                                        1998            1997

<S>                                                <C>             <C>
Revenues:
   Product revenues                                $ 25,021,000    $ 19,895,000
   Contract revenues                                  2,355,000       2,618,000
                                                   ------------    ------------

Total revenues                                       27,376,000      22,513,000
Cost of revenues:
   Cost of product revenues                          10,625,000       9,329,000
   Cost of contract revenues                          1,721,000       2,158,000
                                                   ------------    ------------

Total cost of revenues                               12,346,000      11,487,000
                                                   ------------    ------------

Gross profit                                         15,030,000      11,026,000

Operating expenses:
   Research and development                           2,788,000       2,465,000
   Selling, general and administrative                5,590,000       5,155,000
                                                   ------------    ------------

                                                      8,378,000       7,620,000
                                                   ------------    ------------

Operating income                                      6,652,000       3,406,000

Interest income                                         400,000         392,000
Interest expense                                       (412,000)       (376,000)
Other income (expense), net                             108,000          (5,000)
                                                   ------------    ------------

Income before taxes and minority interest             6,748,000       3,417,000

Income taxes                                          2,228,000         920,000

                                                   ------------    ------------

Income before minority interest                       4,520,000       2,497,000

Minority interest                                       (55,000)         19,000

                                                   ------------    ------------

Net income                                         $  4,465,000    $  2,516,000
                                                   ============    ============

Net income per share-basic                         $       0.25    $       0.15
                                                   ============    ============

Net income per share-assuming dilution             $       0.24    $       0.13
                                                   ============    ============

Weighted average shares outstanding                  17,586,000      17,352,000
                                                   ============    ============

Weighted average shares outstanding-assuming
    dilution                                         18,853,000      18,732,000
                                                   ============    ============
</TABLE>
See accompanying notes.



<PAGE>
<TABLE>
                                   ATMI, Inc.
                      Consolidated Statement of Cash Flows
                                   (unaudited)
<CAPTION>
                                                   Three months ended March 31,
                                                         1998            1997

<S>                                                <C>             <C>
Operating activities
Net income                                         $  4,465,000    $  2,516,000
Adjustments to reconcile net income to net
   cash provided by operating activities:
     Depreciation and amortization                    1,493,000       1,306,000
     Deferred income taxes                                3,000         333,000
     Minority interest in net earnings of
       consolidated subsidiaries                         55,000         (19,000)
     Changes in operating assets and liabilities
       Increase in accounts and notes receivable       (395,000)     (2,392,000)
       Increase in inventory                         (1,574,000)       (871,000)
       Decrease (increase) in other assets              280,000      (1,603,000)
       Increase in accounts payable                     309,000       1,546,000
       Increase in accrued expenses                     175,000         351,000
       (Decrease) increase in other liabilities      (2,143,000)         96,000
                                                   ------------    ------------

Total adjustments                                    (1,797,000)     (1,253,000)
                                                   ------------    ------------

Net cash provided by operating activities             2,668,000       1,263,000
                                                   ------------    ------------

Investing activities
Capital expenditures                                 (2,197,000)     (3,330,000)
Long term investment                                       --          (250,000)
(Purchase) sale of marketable securities, net       (53,988,000)        493,000
                                                   ------------    ------------

Net cash used by investing activities               (56,185,000)     (3,087,000)
                                                   ------------    ------------

Financing activities
Principal payments on capital lease obligations        (893,000)       (443,000)
Principal payments on notes payable                    (366,000)       (350,000)
Proceeds from sale of common shares, net             55,722,000            --
Proceeds from the exercise of stock options
    and warrants                                        101,000         141,000
                                                   ------------    ------------

Net cash provided (used) by financing activities     54,564,000        (652,000)
                                                   ------------    ------------

Effects of exchange rate changes on cash                 31,000         (27,000)
Net increase (decrease) in cash and cash
    equivalents                                       1,078,000      (2,503,000)
Cash and cash equivalents, beginning
   of period                                         11,550,000      12,574,000
                                                   ------------    ------------

Cash and cash equivalents, end of period           $ 12,628,000    $ 10,071,000
                                                   ============    ============
</TABLE>
See accompanying notes.
<PAGE>
                                   ATMI, Inc.
               Notes To Consolidated Interim Financial Statements
                                   (unaudited)


1. Basis of Presentation

     The  accompanying  unaudited  interim  financial  statements of ATMI,  Inc.
("ATMI" or the "Company") have been prepared in accordance with the instructions
to Form 10-Q and Rule  10.01 of  Regulation  S-X and do not  include  all of the
financial  information and disclosures required by generally accepted accounting
principles.

     In the opinion of the  management of ATMI,  Inc. the financial  information
contained herein has been prepared on the same basis as the audited Consolidated
Financial  Statements  contained in the  Company's  Form 10-K for the year ended
December 31, 1997, and includes adjustments (consisting only of normal recurring
adjustments)  necessary to present  fairly the unaudited  quarterly  results set
forth herein. The Company's quarterly results have, in the past, been subject to
fluctuation and, thus, the operating results for any quarter are not necessarily
indicative of results for any future fiscal period.

2. Per Share Data

     In 1997, the Financial  Accounting  Standards  Board (FASB) issued SFAS No.
128, "Earnings per Share," which was adopted in the fourth quarter of 1997. This
new  rule  changes  the way  earnings  per  share  is  calculated  and  requires
restatement of all reported prior period  amounts.  Under the new  requirements,
basic  earnings  per  share  is  calculated  by  dividing  net  earnings  by the
weighted-average  number of common  shares  outstanding  during the period.  The
diluted earnings per share computation includes the effect of shares which would
be issuable  upon the  exercise of  outstanding  stock  options,  reduced by the
number of shares  which are  assumed to be  purchased  by the  Company  from the
resulting proceeds at the average market price during the period.

     The following table presents the computation of basic and diluted  earnings
per share for the three months ended March 31:

<TABLE>
<S>                                                   <C>           <C>
                                                           1998          1997
                                                      ------------   -----------

 Numerator:
    Net income                                         $ 4,465,000   $ 2,516,000
                                                       ===========   ===========

 Denominator:
    Denominator for basic earnings per share-
    weighted-average share                              17,586,000    17,352,000
       Dilutive effect of contingent shares related
         to the ADCS Group acquisition                     700,000       700,000
       Dilutive effect of employee stock options
         and warrants, net of tax benifit                  567,000       680,000
                                                        ----------    ----------
    Denominator for diluted earnings per share          18,853,000    18,732,000
                                                        ==========    ==========

     Net income per share-basic                        $      0.25   $      0.15
                                                       ===========   ===========

     Net income per share-assuming dilution            $      0.24   $      0.13
</TABLE>
                                                       ===========   ===========

3. Inventory

Inventory is comprised of the following:

<TABLE>
<S>                                 <C>                     <C>
                                      March 31,             December 31,
                                         1998                    1997
                                    ------------            ------------

     Raw materials                  $ 7,954,000             $ 6,682,000
     Work in process                    934,000                 946,000
     Finished goods                   1,386,000               1,074,000
                                      ---------               ---------
                                     10,274,000               8,702,000
     Obsolescence reserve              (983,000)               (985,000)
                                       --------                --------

                                    $ 9,291,000             $ 7,717,000
                                    ============            ===========
</TABLE>

4. Comprehensive Income

     During the first quarter of 1998,  the Company  adopted FASB  Statement No.
130, Reporting Comprehensive Income. Statement No. 130 requires the reporting of
comprehensive  income in addition to net income from  operations.  Comprehensive
income  is a  more  inclusive  financial  reporting  methodology  that  includes
disclosure  of certain  financial  information  that  historically  has not been
recognized in the calculation of net income.

     During  the first  quarter of 1998,  the  Company  engaged in  transactions
involving foreign  currency,  resulting in an unrealized gain of $173,000 before
tax. The following  table presents the  computation of  comprehensive  income at
March 31:


<TABLE>
<S>                                                 <C>             <C>
                                                         1998           1997
                                                    -----------     -----------

Net income                                          $ 4,465,000     $ 2,516,000
                                                    -----------     -----------
Other comprehensive income, before tax:
   Foreign currency translation adjustments             173,000         (27,000)
                                                    -----------     -----------

Other comprehensive income, net of tax              $ 4,638,000     $ 2,489,000
                                                    ===========     ===========
</TABLE>



5. Merger and Acquisition

     On February  20,  1998,  the Company  announced  that it had entered into a
definitive  merger agreement with NOW  Technologies,  Inc. ("NOW  Technologies")
pursuant to which NOW Technologies would become a wholly-owned subsidiary of the
Company.  The closing of the merger  agreement is subject to the approval of the
shareholders of NOW Technologies and appropriate  government agencies and to the
satisfaction of other customary conditions.  While the exact number of shares of
Common Stock to be issued by the Company to the shareholders of NOW Technologies
will not be  determined  until the third  trading day prior to the closing,  the
number of shares to be issued  will  range  from 1.32  million  to 1.59  million
(excluding shares issuable upon exercise of outstanding options).  The merger is
intended to be treated as a tax-free reorganization and to be accounted for as a
pooling of interests.  NOW  Technologies  is a manufacturer  and  distributor of
semiconductor materials packaging systems, particularly for advanced photoresist
materials.  A non-recurring charge of approximately  $2,000,000 will be expensed
in conjunction with this merger in the period when the transaction is completed.

<PAGE>
6. Public Offering

     On March 31, 1998, the Company completed a registered  underwritten  public
offering of 4,720,000  shares of the  Company's  Common  Stock.  Of such shares,
2,000,000  shares  were sold by the Company  and  2,720,000  shares were sold by
certain stockholders of the Company. In addition,  the Company and those certain
stockholders granted to the underwriters an option to purchase up to 257,291 and
450,709   additional   shares   of   Common   Stock,   respectively,   to  cover
over-allotments,  if any. On April 2, 1998, the  over-allotment was exercised in
full.

     As a  result  of the  offering  at the end of  March  and  exercise  by the
underwriters  of the  over-allotment  in early April,  the Company  received net
proceeds of approximately $55.7 and $7.2 million, respectively, from the sale of
2.26 million shares.

     Approximately $55.7 million,  net of $0.5 million of issuance cost has been
reflected on the balance sheet at March 31, 1998.

<PAGE>
Item 2.  Management's  Discussion  and Analysis of Financial  Condition and
         Results of Operations.

Overview

     ATMI was  incorporated in Delaware in 1997 and is the successor  registrant
to Advanced Technology Materials,  Inc. which was incorporated in Connecticut in
1986 and  reincorporated  in Delaware in 1987. The Company is a leading supplier
of  specialty   thin  film   materials   and  delivery   systems,   point-of-use
environmental  equipment and epitaxial processing services for the semiconductor
industry.  Product  revenues  include  revenues from the sale of consumable thin
film  materials  and  materials  delivery  systems,   environmental   equipment,
consumable resins for effluent abatement and processed epitaxial wafers. Product
revenues are recognized  upon the shipment of those  products.  The Company also
derives revenues from contract  research and development  activities  related to
high  performance   semiconductor  materials  and  devices  and  from  royalties
generated under various  license  agreements.  Contract  revenues are recognized
using a percentage-of-completion  method based upon costs incurred and estimated
future costs.

     A substantial  majority of ATMI's  revenues track "wafer starts" within the
semiconductor  industry,  or the volume of silicon  wafers  processed into fully
functional  semiconductor  devices. These include revenues derived from the sale
of specialty  thin film  materials  that are used in chemical  vapor  deposition
("CVD")  processes and the delivery systems for these  materials.  Manufacturers
seek to replenish these consumable materials on a continuing basis. Furthermore,
once the Company's specialty materials are qualified for a specific process, the
Company's customers typically source materials from the Company for the lifetime
of the process,  generating a recurring revenue stream.  Similarly,  the Company
derives a  recurring  revenue  stream  from the sale of resins  that are used in
certain of its environmental  equipment  products.  Additionally,  the Company's
epitaxial wafer processing  services revenues are directly tied to the number of
wafers  processed  for the  Company's  customers.  A smaller  portion  of ATMI's
revenues,  principally those derived from  environmental  equipment sales, track
new semiconductor plant construction.

     The Company's  products are based primarily on proprietary and patented CVD
technologies  used in the manufacture of  semiconductor  devices.  The Company's
strategy has been to use these  technologies to develop and, in conjunction with
industry collaborators, sequentially introduce products into high growth markets
of the semiconductor industry. Using this phased commercialization strategy, the
Company  has  been  able to  develop  its core CVD  technologies  and  establish
businesses to support further commercialization of its products. The Company has
also used a targeted  acquisition  strategy to assist in building  critical mass
and market position in each of the markets it serves.

     The Company has used a targeted  acquisition strategy to assist in building
critical mass and market position in the niches the Company serves. In 1994, ATM
acquired Vector Technical Group,  Inc.  ("Vector"),  and in conjunction with the
sale of certain  Novapure  product lines to Millipore  Corporation  in September
1994,  formed  ATMI  EcoSys  Corporation  ("EcoSys")  by  merging  the  retained
operations of Novapure with those of Vector.  In 1995, ATM acquired the Guardian
product line from Messer Griesheim Industries, Inc. and folded that product line
into EcoSys. In 1995, ATM acquired  Epitronics  Corporation,  and in early 1996,
combined that business with the ATM's former Diamond Electronics  division under
the Epitronics  name. In October 1997, ATMI acquired the ADCS Group and LSL. The
ADCS Group  manufactures and distributes  ultra-high purity  semiconductor  thin
film materials.  LSL was an outsourcer of epitaxial processing of silicon wafers
using chemical vapor deposition technology to meet customer specifications.  The
operations  of the ADCS  Group were  integrated  with the  operations  of ATMI's
NovaMOS  division  under  the  ADCS  name  and the  operations  of LSL  with the
operations of ATMI's Epitronics division under the Epitronics name.

<PAGE>
     The following table sets forth, for the periods  indicated,  the percentage
relationship to total revenues of certain items in ATMI's Consolidated Statement
of Income:

<TABLE>
<CAPTION>
                          Three Months Ended March 31,
                                    1998 1997

<S>                                                       <C>         <C>
Product revenues                                           91.4%       88.4%
Contract revenues                                           8.6        11.6
                                                          -----       -----
      Total revenues                                      100.0       100.0
Cost of revenues                                           45.1        51.0
                                                          -----       -----
Gross profit                                               54.9        49.0
Operating expenses:
      Research and development                             10.2        11.0
      Selling, general and administrative                  20.4        22.9
                                                          -----       -----
            Total operating expenses                       30.6        33.9
                                                          -----        ----
Operating income                                           24.3        15.1
Interest income (expense), net                              0.0         0.1
Other income, net                                           0.4         0.0
                                                          -----       -----
Income before income taxes and minority interest           24.7        15.2
Income taxes                                                8.2         4.1
                                                          -----       -----
Income before minority interest                            16.5        11.1
Minority interest                                          (0.2)        0.1
                                                          -----        ----
Net income                                                 16.3%       11.2%
                                                          =====       =====
</TABLE>


Results of Operations

Three Months Ended March 31, 1998 and 1997.

     Revenues.  Total revenues  increased 21.6% to approximately  $27,376,000 in
the three months ended March 31, 1998 from approximately $22,513,000 in the same
three month period in 1997.  Product  revenues  increased 25.8% to approximately
$25,021,000  in the  three  months  ended  March  31,  1998  from  approximately
$19,895,000  in the comparable  period in 1997.  The product  revenue growth was
primarily  attributable  to  the  continued  expansion  of  SDS  product  sales,
increased  material sales at ADCS and growth in sales of silicon epi services at
Epitronics. Contract revenues decreased 10.0% to approximately $2,355,000 in the
quarter  ended March 31, 1998 from  approximately  $2,618,000  in the same three
month  period in 1997.  The  decrease  in the 1998  quarter  reflected a general
decrease in government funding of the Company's  research  activities as well as
completion of various existing government contracts.

     Gross Profit. Gross profit increased 36.3% to approximately  $15,030,000 in
the quarter ended March 31, 1998 from  approximately  $11,026,000 in the quarter
ended March 31, 1997.  Gross margin  increased to 54.9% of revenues in the three
month period in 1998 from 49.0% of revenues in the three month period in 1997.

     Gross  profit  from  product  revenues  increased  36.3%  to  approximately
$14,396,000  in the  three  months  ended  March  31,  1998  from  approximately
$10,566,000  in the same three month period a year ago.  Gross margin on product
revenues  increased  to 57.5% in the 1998 period from 53.1% in the 1997  period.
This  increase  was due  principally  to a shift in product mix  towards  higher
margin consumable product lines, which includes the SDS product.

     Gross profit on contract revenues increased 37.8% to approximately $634,000
in the  quarter  ended March 31,  1998 from  approximately  $460,000 in the same
quarter a year ago. Gross margin on contract revenues  increased to 26.9% in the
first quarter of 1998 from 17.8% in the first  quarter of 1997.  The increase in
contract  margin  resulted  from the  completion  of  certain  firm-fixed  price
contracts in the quarter. Additionally,  contract margins can vary slightly from
year to year  based on the mix of  cost-type,  firm  fixed  price and cost share
arrangements.

     Research  and  Development  Expenses.  Research  and  development  expenses
increased  13.1% to  approximately  $2,788,000 in the first three months of 1998
from approximately $2,465,000 in the first three months of 1997. The increase in
the first quarter of 1998 was principally due to development efforts surrounding
the Company's advanced thin film materials  technology and  application-specific
product  development  efforts within the recently announced Emosyn venture. As a
percentage of revenues,  research and development expenses decreased to 10.2% in
the 1998 quarter from 11.0% in the 1997 quarter.

     Selling,  General  and  Administrative   Expenses.   Selling,  general  and
administrative expenses increased 8.4% to approximately  $5,590,000 in the three
months  ended March 31,  1998 from  approximately  $5,155,000  in the same three
month  period in 1997.  The increase in the 1998  quarter was  primarily  due to
increased administrative costs, increased commissions on higher product revenues
and increased marketing activities.  As a percentage of revenues, these expenses
decreased  to  20.4%  in the  three  month  period  in 1998  from  22.9%  in the
comparable  period in 1997 due to the faster  growing  consumable  product lines
requiring less variable selling cost than the equipment lines.

     Other Income,  Net.  Other income,  including  interest  income and expense
increased  to  approximately  $96,000 in the  quarter  ended March 31, 1998 from
approximately  $11,000 in the quarter ended March 31, 1997.  The increase in the
1998 quarter related to a decrease in interest  expense as a result of decreases
in  outstanding  debt  balances  and an increase  in  interest  income due to an
increase in the cash position of the Company at March 31, 1998 compared to March
31, 1997.  There was no significant  increase in interest income from the public
offering due to its completion at the end of the first quarter of 1998.

     Income Taxes.  ATMI's income tax expense  related  primarily to federal and
state  taxes on income  generated,  partially  offset  by  various  foreign  and
research and development  credits  available.  Income tax expense in the quarter
ended March 31, 1998 was  $2,228,000 up from $920,000 in the same quarter a year
ago. The Company's loss carryforwards were fully utilized in 1997, causing a 33%
effective tax rate at March 31, 1998.

     Earnings per Share.  Earnings per share-assuming  dilution improved to $.24
for the first quarter of 1998  compared with a $.13 earnings per  share-assuming
dilution in the first  quarter of 1997.  There was no material  change in shares
outstanding  for the first quarter of 1998 when compared to the first quarter of
1997.

Liquidity and Capital Resources

     To date,  the  Company  has  financed  its  activities  through the sale of
equity,  external  research  and  development  funding,  various  lease and debt
instruments and  operations.  The Company's  working capital  increased to $98.2
million at March 31, 1998 from $39.9 million at December 31, 1997, due primarily
to a public offering completed in late March, 1998.

     Net cash provided by operations was  approximately  $2.7 million during the
three months ended March 31, 1998 due primarily to the  increased  profitability
of  operations  compared to $1.3  million  provided  during the same three month
period in 1997. Working capital increases in the first quarter of 1998 and 1997,
most notably in accounts receivables and inventories,  resulted in a significant
use of cash,  which were partially  offset by increases in accounts  payable and
accrued expenses.

     In March and April 1998,  the Company  completed a registered  underwritten
public  offering  of  5,428,000  shares of its  Common  Stock.  Of such  shares,
2,257,291  shares were sold by ATMI,  and 3,170,709  shares were sold by certain
stockholders of ATMI. Net proceeds,  from the offering including exercise by the
underwriters of the over-allotment, to ATMI were approximately $62.9 million.

<PAGE>
     The Company generated approximately $54.6 million from financing activities
during the 1998 quarter, primarily due to the completion of the public offering,
compared to a utilization of cash of  approximately  $0.7 million from financing
activities  in the first  quarter of 1997.  The Company  invested  approximately
$54.0  million of the  proceeds  raised  from the sale of its Common  Stock into
marketable  securities for future  working  capital  requirements  and potential
merger and acquisition activities.

     During  the  first  quarter  of 1998,  cash was  used for the  purchase  of
approximately   $2.2  million  in  capital   equipment,   primarily  related  to
installation of additional manufacturing capacity in Danbury, Connecticut and at
the ADCS-manufacturing  facilities in Burnet, Texas In the previous year's first
quarter, the Company incurred approximately $3.3 million in capital expenditures
primarily related to installation of SDS  manufacturing  capacity in Danbury and
epitaxial capacity at Epitronics in Phoenix, Arizona.

     ATMI  believes  the  proceeds  from its public  offering of Common Stock in
combination with existing cash balances, marketable securities, existing sources
of liquidity and anticipated funds from operations, including those of the newly
acquired  businesses,  will satisfy its projected working capital and other cash
requirements through at least the end of 1999. However,  ATMI believes the level
of financing resources available to it is an important competitive factor in its
industry  and may  seek  additional  capital  prior  to the end of that  period.
Additionally,  ATMI considers,  on a continuing basis, potential acquisitions of
technologies and businesses  complementary to its current  business.  Other than
the   proposed   acquisition   of  NOW   Technologies,   there  are  no  present
understandings,  commitments or agreements with respect to any such acquisition.
However, any such transaction may affect ATMI's future capital needs.

Safe Harbor Statement

     Statements  which  are not  historical  facts in this  report  are  forward
looking statements, made on a good faith basis. Such forward looking statements,
including  those  expressing  confidence  about the Company's  expectations  for
demand and sales of new and existing products, semiconductor industry and market
segment growth,  and market and technology  opportunities,  all involve risk and
uncertainties.  Actual  results  may  differ  materially  from  forward  looking
statements, for reasons including, but not limited to, changes in the pattern of
semiconductor  industry  growth or the markets the Company  sells  products for,
customer  interest in the Company's  products,  product and market  competition,
delays or problems in the  development  and  commercialization  of the Company's
products,  or  technological  change  affecting  the  Company's  core  thin film
competencies.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

     Not applicable.

PART II- OTHER INFORMATION

Item 6.  Exhibits and Reports on Form 8-K.

a. Exhibits.

    Exhibit No.                                Description
     2.01      Merger Agreement by and among ATMI, Inc., Glide Acquisition,
               Inc. and NOW Technologies, Inc dated as of
               February 19, 1998 (Exhibit 2.03 to ATMI's Registration  Statement
               on  Form  S-1,  Registration  No.333-46609  and  incorporated  by
               reference herein)

     27.01     Financial Data Schedule (Filed herewith)



b. Reports on Form 8-K.

     On February 11, 1998,  the Company filed a Current Report on Form 8-K dated
February 11, 1998  reporting in Item 5 thereof the announced  financial  results
for the fourth quarter of 1997 and fiscal year ended December 31, 1997.

     On February 19, 1998,  the Company filed a Current Report on Form 8-K dated
February 19, 1998  reporting  in Item 5 thereof the  entering  into a definitive
merger agreement with NOW Technologies, Inc.

<PAGE>
                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                                             ATMI, Inc.

May 12, 1998

                        By _____________________________
                            Eugene G. Banucci, Ph.D.,
                             President, Chief Executive Officer, Chairman of the
                                                              Board and Director


                        By _____________________________
                              Daniel P. Sharkey, Vice President, Chief Financial
                                Officer and Treasurer (Chief Accounting Officer)




================================================================================


                                  EXHIBIT INDEX


                                                                   Sequentially
                                                                     Numbered
Exhibit No.         Description                                        Page

      2.01   Merger Agreement by and among ATMI, Inc., Glide  Acquisition,  Inc.
             and NOW  Technologies,  Inc dated as of February 19, 1998  (Exhibit
             2.03 to ATMI's  Registration  Statement  on Form S-1,  Registration
             No. 333-46609 and incorporated by reference herein)

     27.0    Financial Data Schedule (Filed herewith)



WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>


<ARTICLE>                                                 5
<MULTIPLIER>                                            1000
       
<S>                                              <C>               <C>                       <C>             <C>
<PERIOD-TYPE>                                    12-MOS          12-MOS                    3-MOS           3-MOS
<FISCAL-YEAR-END>                                Dec-31-1995     Dec-31-1996               Dec-31-1997     Dec-31-1998
<PERIOD-END>                                     Dec-31-1995     Dec-31-1996               Mar-31-1997     Mar-31-1998
<CASH>                                                 11962           12574                     10583           12628
<SECURITIES>                                           21856           18238                     17218           71449
<RECEIVABLES>                                          12890<F1>       13804<F1>                 16196<F1>       20164<F1>
<ALLOWANCES>                                               0               0                         0               0
<INVENTORY>                                             3579            6503                      8641            9291
<CURRENT-ASSETS>                                       52343           56036                     57790          117444
<PP&E>                                                 19522<F2>       30660<F2>                 34494<F2>       36810<F2>
<DEPRECIATION>                                             0               0                         0               0
<TOTAL-ASSETS>                                         78590           93191                     99366          160747
<CURRENT-LIABILITIES>                                  18122           19450                     22328           19290
<BONDS>                                                    0               0                         0               0
                                      0               0                         0               0
                                                0               0                         0               0
<COMMON>                                                 178             179                       183             202
<OTHER-SE>                                             45118           55473                     58102          122333
<TOTAL-LIABILITY-AND-EQUITY>                           78590           93191                     99366          160747
<SALES>                                                60172           88661                     22513           27376
<TOTAL-REVENUES>                                       60172           88661                     22513           27376
<CGS>                                                  29723           41231                     11487           12346
<TOTAL-COSTS>                                          29723           41231                     11487           12346
<OTHER-EXPENSES>                                        5697<F3>        9838<F3>                 2465<F3>         2788<F3>
<LOSS-PROVISION>                                           0               0                         0               0
<INTEREST-EXPENSE>                                      1320            1635                       376             412
<INCOME-PRETAX>                                         7966           15024                      3417            6748
<INCOME-TAX>                                            2888            3158                       920            2228
<INCOME-CONTINUING>                                        0               0                         0               0
<DISCONTINUED>                                             0               0                         0               0
<EXTRAORDINARY>                                            0               0                         0               0
<CHANGES>                                                  0               0                         0               0
<NET-INCOME>                                            5088           12017                      2516            4465
<EPS-BASIC>                                              .32             .70                       .15             .25
<EPS-ASSUMING DILUTION>                                  .30             .65                       .13             .24


<FN>
<F1>Net of  allowance  for doubtful  accounts,  consistent  with  balance  sheet
presentation.
<F2>Net of accumulated depreciation, consistent with balance sheet
presentation.
<F3>Research and development expenses
</FN>
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission